×
Agilon Health EBITDA 2020-2024 | AGL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Agilon Health ebitda from 2020 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
View More
Agilon Health EBITDA 2020-2024 | AGL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Agilon Health ebitda from 2020 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company Name
Market
Cap
Elevance Health (ELV)
$93.4B
Cencora (COR)
$48.3B
DiDi Global (DIDIY)
$22.2B
Natera (NTRA)
$22.1B
ICON (ICLR)
$17.7B
Viatris (VTRS)
$16B
Avantor (AVTR)
$14.1B
Revvity (RVTY)
$13.6B
CochLear (CHEOY)
$12.8B
Solventum (SOLV)
$12.2B
BioMerieux (BMXMF)
$11.9B
Medpace Holdings (MEDP)
$10.5B
Charles River Laboratories (CRL)
$10B
HealthEquity (HQY)
$9.1B
Doximity (DOCS)
$9B
Sonic Healthcare (SKHHY)
$8.9B
Bausch + Lomb (BLCO)
$6.9B
Life Times (LTH)
$5.1B
Organon (OGN)
$3.9B
Sotera Health (SHC)
$3.6B
BrightSpring Health Services (BTSG)
$3.3B
Surgery Partners (SGRY)
$2.9B
Concentras Parent (CON)
$2.8B
PACS (PACS)
$2.5B
Alignment Healthcare (ALHC)
$2.3B
Ardent Health Partners (ARDT)
$2.3B
Premier (PINC)
$2.2B
GeneDx Holdings (WGS)
$2.2B
Ryman Healthcare (RYHTY)
$2B
GoodRx Holdings (GDRX)
$1.9B